Ogkologos | Ogkologos.com | Page 55

Home Authors Posts by Ogkologos

4396 POSTS 0 COMMENTS

Pelabresib Plus Ruxolitinib Improves Signs of Underlying Myelofibrosis Pathobiology and Provides...

Ogkologos - March 25, 2025

No Improvement in OS or PFS from Sacituzumab Govitecan Compared with...

Ogkologos - March 24, 2025

Intensive Program Helps People Being Screened for Lung Cancer Quit Smoking

Ogkologos - March 21, 2025

EMA Recommends Extension of Indications for Trastuzumab Deruxtecan to Include Treatment...

Ogkologos - March 21, 2025

European Lung Cancer Congress 2025, Paris, France, 26-29 March 2025

Ogkologos - March 20, 2025

FDA Approves Mirdametinib for Adult and Paediatric Patients with NF1 Who...

Ogkologos - March 20, 2025

Real-World Patients with Cancer Show Lower Survival Times and Treatment-Associated Survival...

Ogkologos - March 18, 2025

Patients with Breast, Colorectal, and Pancreatic Cancers With ATM, CHEK2, or...

Ogkologos - March 18, 2025

Manageable Safety Profile and Antitumour Activity of Zongertinib in Pretreated Patients...

Ogkologos - March 17, 2025

EMA Recommends Extension of Therapeutic Indications for Nivolumab and Ipilimumab to...

Ogkologos - March 14, 2025

1...545556...440 Page 55 of 440

MOST POPULAR

Median Survival Times for Two Forms of Advanced Breast Cancer Have...

November 9, 2021

Activity of Targeted/Immune Therapy Approach in Patients with Advanced Urothelial Cancer

May 11, 2021

Coming Soon: Medicare Drug Price Negotiations

September 1, 2023

Cancer Immunotherapy Drug Simultaneously Targets Two Proteins that Block Immune Response

April 4, 2018

HOT NEWS

Study Estimates That 22% Of Breast Cancers Are Overdiagnosed And Won’t...

FDA Approves Brentuximab Vedotin with Lenalidomide and Rituximab for Relapsed or...

15% of People With Lung Cancer Have an Inherited Mutation for...

When Both Tumour-Infiltrating Lymphocytes and Gene Expression are Available, the Prognostic...